Pingping Xue
Impact in
- Obstetrics and Gynecology top 2%
- Pregnancy and preeclampsia studies
-
- MicroRNA in disease regulation
Papers in
-
- Pregnancy and preeclampsia studies 7
- Gynecological conditions and treatments 2
-
- Protease and Inhibitor Mechanisms 2
- MicroRNA in disease regulation 2
- Co-authors
- Yali Hu (6 shared papers)Xiaofan Yang (9 shared papers)Li Shen (4 shared papers)Zhenbing Chen (6 shared papers)Haixiang Sun (4 shared papers)Zhenyu Diao (4 shared papers)Mingming Zheng (4 shared papers)Ping Gong (3 shared papers)
- Journals
- Placenta (4 papers)Chemico-Biological Interactions (2 papers)Frontiers in Endocrinology (2 papers)Biomedicine & Pharmacotherapy (2 papers)Cancer Chemotherapy and Pharmacology (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Pingping Xue
30 papers receiving 756 citations
Peers
Comparison fields: 5 of 70
- Obstetrics and Gynecology 266
- Cancer Research 64
- Immunology 81
- Molecular Biology 236
- Molecular Medicine 21
Countries citing papers authored by Pingping Xue
This map shows the geographic impact of Pingping Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingping Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingping Xue more than expected).
Fields of papers citing papers by Pingping Xue
This network shows the impact of papers produced by Pingping Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingping Xue. The network helps show where Pingping Xue may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingping Xue, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 112 | |
| 2 | 2012 | 101 | |
| 3 | 2015 | 86 | |
| 4 | 2016 | 79 | |
| 5 | 2019 | 44 | |
| 6 | 2021 | 35 | |
| 7 | 2017 | 33 | |
| 8 | 2018 | 31 | |
| 9 | 2021 | 31 | |
| 10 | 2022 | 24 | |
| 11 | 2022 | 23 | |
| 12 | 2013 | 20 | |
| 13 | 2013 | 18 | |
| 14 | 2017 | 18 | |
| 15 | 2022 | 17 | |
| 16 | 2021 | 14 | |
| 17 | 2022 | 14 | |
| 18 | 2014 | 13 | |
| 19 | 2024 | 12 | |
| 20 | 2021 | 9 |
About Pingping Xue
Pingping Xue is a scholar working on Obstetrics and Gynecology, Cancer Research, Oncology, Immunology and Molecular Biology, having authored 30 papers that have together received 768 indexed citations. Recurring topics across this work include Pregnancy and preeclampsia studies (7 papers), Reproductive Biology and Fertility (4 papers), Reproductive System and Pregnancy (4 papers), Muscle Physiology and Disorders (4 papers), RNA modifications and cancer (3 papers), Protease and Inhibitor Mechanisms (2 papers), Gynecological conditions and treatments (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Obstetrics and Gynecology (266 citations), Cancer Research (64 citations), Immunology (81 citations), Molecular Biology (236 citations) and Molecular Medicine (21 citations). Pingping Xue has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Yali Hu, Xiaofan Yang, Li Shen, Zhenbing Chen, Haixiang Sun, Zhenyu Diao, Mingming Zheng, Ping Gong, Meng Yuan and Hans‐Günther Machens. Their work appears in journals such as Placenta, Chemico-Biological Interactions, Frontiers in Endocrinology, Biomedicine & Pharmacotherapy and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.